“…Despite valuable insights into the structure and regulation of Cx HCs and GJCs [ 1 , 3 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 ], one may have the impression that matters arising from the lack of Cx subtype-specific inhibitors and pertinent structural issues stayed somewhat unexplored [ 58 , 59 ].…”